Sharekhan

#SharekhanResearch retains Buy on #SanofiIndia(PT Rs9250) acceleration in diabetes prcts, strng gwth in top prdcts… https://t.co/ehIRqGsAHs #SharekhanResearch #SanofiIndia

#SharekhanResearch retain Buy on Mahindra Lifespace Devs with unchanged PT of Rs340, To receive 9.2acre land at Kan… https://t.co/Rf7prkS1Qn #SharekhanResearch

Thinking about investing in #SovereignGoldBonds (SGB) Series X but are a bit unsure? We bring everything you need… https://t.co/UYKMlQqsfR #SovereignGoldBonds

#StockMarket opportunities rarely knock twice. Don’t miss out due to inaction! Check out our 3R Research ACTIONABL… https://t.co/BD5dkU5RwM #StockMarket

#SharekhanResearch maintains Buy on Oil India with PT of Rs290; expect 40% PAT CAGR over FY21-24E on elevated oil p… https://t.co/REv4a37BUg #SharekhanResearch

#SharekhanResearch retains Buy rating on #Biocon(PT Rs 420); inks deal with Viatris’ to buy its biosimilar assets,… https://t.co/IRgfT0uLW8 #SharekhanResearch #Biocon

#SharekhanResearch retain Buy on Ultratech with unchanged PT of Rs9200, Pan-India avg cement prices up 6%yoy for Ja… https://t.co/6i0GG608D0 #SharekhanResearch

Want to know how to customize conditions on your #trading platform? Check out our recorded session here:… https://t.co/wbcZ0ikqFE #trading

#StockMarket opportunities rarely knock twice. Don’t miss out due to inaction! Check out our 3R Research ACTIONABL… https://t.co/ISRBAw4uym #StockMarket